Literature DB >> 22318330

Basal HIF-1α expression levels are not predictive for radiosensitivity of human cancer cell lines.

D Schilling1, C Bayer, K Emmerich, M Molls, P Vaupel, R M Huber, G Multhoff.   

Abstract

BACKGROUND AND
PURPOSE: High levels of hypoxia inducible factor (HIF)-1α in tumors are reported to be associated with tumor progression and resistance to therapy. To examine the impact of HIF-1α on radioresistance under normoxia, the sensitivity towards irradiation was measured in human tumor cell lines that differ significantly in their basal HIF-1α levels.
MATERIAL AND METHODS: HIF-1α levels were quantified in lysates of H1339, EPLC-272H, A549, SAS, XF354, FaDu, BHY, and CX- tumor cell lines by ELISA. Protein levels of HIF-1α, HIF-2α, carbonic anhydrase IX (CA IX), and GAPDH were assessed by Western blot analysis. Knock-down experiments were performed using HIF-1α siRNA. Clonogenic survival after irradiation was determined by the colony forming assay.
RESULTS: According to their basal HIF-1α status, the tumor cell lines were divided into low (SAS, XF354, FaDu, A549, CX-), intermediate (EPLC-272H, BHY), and high (H1339) HIF-1α expressors. The functionality of the high basal HIF-1α expression in H1339 cells was proven by reduced CA IX expression after knocking-down HIF-1α. Linear regression analysis revealed no correlation between basal HIF-1α levels and the survival fraction at either 2 or 4 Gy in all tumor cell lines investigated.
CONCLUSION: Our data suggest that basal HIF-1α levels in human tumor cell lines do not predict their radiosensitivity under normoxia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318330     DOI: 10.1007/s00066-011-0051-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  33 in total

Review 1.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

Review 2.  Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy.

Authors:  Mark W Dewhirst; Yiting Cao; Chuan Yuan Li; Benjamin Moeller
Journal:  Radiother Oncol       Date:  2007-06-08       Impact factor: 6.280

3.  Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells: the role of HIF.

Authors:  Mareike Ströfer; Wolfgang Jelkmann; Reinhard Depping
Journal:  Strahlenther Onkol       Date:  2011-06-27       Impact factor: 3.621

4.  Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control.

Authors:  Daniel Zips; Simon Böke; Theresa Kroeber; Andreas Meinzer; Kerstin Brüchner; Howard D Thames; Michael Baumann; Ala Yaromina
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

5.  Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.

Authors:  M Krieg; R Haas; H Brauch; T Acker; I Flamme; K H Plate
Journal:  Oncogene       Date:  2000-11-16       Impact factor: 9.867

6.  Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts.

Authors:  Duyen T Dang; Fang Chen; Lawrence B Gardner; Jordan M Cummins; Carlo Rago; Fred Bunz; Sergey V Kantsevoy; Long H Dang
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

7.  Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1alpha.

Authors:  Woo-Young Kim; Seung Hyun Oh; Jong-Kyu Woo; Waun Ki Hong; Ho-Young Lee
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

8.  Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response.

Authors:  Olga Aprelikova; Silvia Pandolfi; Sean Tackett; Mark Ferreira; Konstantin Salnikow; Yvona Ward; John I Risinger; J Carl Barrett; John Niederhuber
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

9.  Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.

Authors:  Kathrin Dellas; Matthias Bache; Steffi U Pigorsch; Helge Taubert; Matthias Kappler; Daniel Holzapfel; Ester Zorn; Hans-Juergen Holzhausen; Gabriele Haensgen
Journal:  Strahlenther Onkol       Date:  2008-03       Impact factor: 3.621

10.  Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha.

Authors:  Denise A Chan; Patrick D Sutphin; Nicholas C Denko; Amato J Giaccia
Journal:  J Biol Chem       Date:  2002-08-16       Impact factor: 5.157

View more
  10 in total

1.  Prognostic value of HIF-1α expression during fractionated irradiation.

Authors:  L Helbig; A Yaromina; S N Sriramareddy; S Böke; L Koi; H D Thames; M Baumann; D Zips
Journal:  Strahlenther Onkol       Date:  2012-09-29       Impact factor: 3.621

2.  A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor.

Authors:  C Ostheimer; M Bache; A Güttler; M Kotzsch; D Vordermark
Journal:  Strahlenther Onkol       Date:  2013-12-11       Impact factor: 3.621

3.  A hypoxia-induced decrease of either MICA/B or Hsp70 on the membrane of tumor cells mediates immune escape from NK cells.

Authors:  Daniela Schilling; Fabian Tetzlaff; Sarah Konrad; Wei Li; Gabriele Multhoff
Journal:  Cell Stress Chaperones       Date:  2014-08-08       Impact factor: 3.667

4.  In vitro hypoxic cytotoxicity and hypoxic radiosensitization. Efficacy of the novel 2-nitroimidazole N,N,N-tris[2-(2-nitro-1H-imidazol-1-yl)ethyl]amine.

Authors:  M Langenbacher; R J Abdel-Jalil; W Voelter; M Weinmann; S M Huber
Journal:  Strahlenther Onkol       Date:  2013-01-31       Impact factor: 3.621

5.  Hypoxia-related molecules HIF-1α, CA9, and osteopontin : predictors of survival in patients with high-grade glioma.

Authors:  O P Erpolat; P U Gocun; M Akmansu; G Ozgun; G Akyol
Journal:  Strahlenther Onkol       Date:  2012-12-22       Impact factor: 3.621

6.  Plasminogen activator inhibitor-1 (PAI-1) expression in relation to hypoxia and oncoproteins in clinical cervical tumors.

Authors:  P C Lara; M Lloret; A Valenciano; B Clavo; B Pinar; A Rey; L A Henríquez-Hernández
Journal:  Strahlenther Onkol       Date:  2012-11-01       Impact factor: 3.621

7.  MicroRNA-17-5p post-transcriptionally regulates p21 expression in irradiated betel quid chewing-related oral squamous cell carcinoma cells.

Authors:  S-Y Wu; K-C Lin; J-F Chiou; S-C Jeng; W-H Cheng; C-I Chang; W-C Lin; L-L Wu; H-L Lee; R-J Chen
Journal:  Strahlenther Onkol       Date:  2013-06-20       Impact factor: 3.621

8.  Radiosensitization of normoxic and hypoxic h1339 lung tumor cells by heat shock protein 90 inhibition is independent of hypoxia inducible factor-1α.

Authors:  Daniela Schilling; Christine Bayer; Wei Li; Michael Molls; Peter Vaupel; Gabriele Multhoff
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

9.  Radiation, inflammation, and immune responses in cancer.

Authors:  Gabriele Multhoff; Jürgen Radons
Journal:  Front Oncol       Date:  2012-06-04       Impact factor: 6.244

10.  MicroRNA-17-5p regulated apoptosis-related protein expression and radiosensitivity in oral squamous cell carcinoma caused by betel nut chewing.

Authors:  Szu-Yuan Wu; Alexander T H Wu; Shing-Hwa Liu
Journal:  Oncotarget       Date:  2016-08-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.